As well as Neogene Therapeutics' NT-125, AstraZeneca threw two other candidates on the cell therapy scrap heap. (Daria Nipot/iStock/Getty Images Plus) AstraZeneca has dropped the lead candidate from ...
AstraZeneca AZN announced an agreement to acquire private biotech, Neogene Therapeutics to build its pipeline of cell-based cancer medicines. The acquisition of Neogene will provide AstraZeneca access ...
AstraZeneca expanded its oncology portfolio Tuesday morning by announcing it reached an agreement to buy Neogene Therapeutics. The British pharma giant is purchasing the clinical-stage biotechnology ...
T-cell therapy company Neogene Therapeutics is being purchased by multinational pharma giant AstraZeneca in a deal potentially worth as much as $320 million that could greatly strengthen the regional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results